DMF section 3.2.S.7 - Stability

  Рет қаралды 557

Fernanda Waechter

Fernanda Waechter

3 ай бұрын

Our aim here is to know for how long the API can be stored in the temperature and humidity conditions it will be exposed to, using the packaging material that was described in the previous section, considering the climate of the country where it is manufactured, as well as the country where it will be used in the drug product formulation.
There are different climate zones in the world, and the most critical condition must be considered for the stability studies. Alternative conditions may be used, in case of a controlled transport chain.
There are various studies that must be performed to understand the API stability.
The first one is the forced degradation study, which may be presented here or as part of the analytical validations in section 3.2.S.4.3. One of the objectives of this study is to expose the API to stressing conditions, so that in a short period of time it is possible to identify which conditions lead to degradation of the API - and which conditions we want to avoid during its life cycle.
This study includes for exposure to light, heat, humidity, oxidation, and acidic and alkaline hydrolytic conditions.
In order to identify if an API is sensitive to light, the ICH Q1B guideline must be followed, which recommends a confirmatory testing for photostability, in which the API must be exposed to at least 1.2 million lux.hour and 200 watt.hour UV light. This study allows us to conclude whether the API is considered photosensitive or not.
Another study is the accelerated stability study, in which the stability of the API will be evaluated in 6 months in conditions a bit more extreme than the normal ones, and the long-term stability study, which must represent the actual conditions to which the API will be exposed throughout its shelf life.
The conditions in such studies depend on the climate zone - e.g. for Zone Ivb, the accelerated stability is done at 40 C and 75% R.H., while the long-term stability is done at 30 C and 75% R.H.
The packaging material where the API is stored during these studies must represent the commercial packaging which was described in section 3.2.S.6.
The API stored in these conditions is tested throughout the time to understand if it is still approved in the quality control specifications. It is not necessary to perform all the tests that are done to release the API, only those which may be impacted by the API degradation.
Besides, we need to be sure that the assay and impurities methods that are used in these studies are in fact considered stability-indicating. And here comes the second objective of the forced degradation study: demonstrating that this combination of methods for assay and impurities is capable of specifically separating and quantifying the API and all the expected degradation impurities.
This means that if the API degrades and there is an increase in formation of impurities, this behaviour must be shown by such methods. So we should not have coelution of the API with impurities, which would hide this degradation. A good resolution between peaks must be shown, as well as the peak purity for the chromatograms.
Our intention in a forced degradation study is to see formation of impurities, so that this can be evaluated, but not in an exaggerated way - we usually look for up to 10% degradation, to avoid secondary degradation products which would not be expected in the real life of the API.
Moreover, ICH Q1B also recommends a photolytic forced degradation, which in general is a more extreme condition than the confirmatory test, since its objective is to form impurities to demonstrate that the method is stability-indicating.
A common deficiency is that there is no degradation in the forced degradation study because the API was not stressed enough. For example the API was exposed to heat for only one day and a conclusion was drawn that the API was stable to heat. The recommendation to seek the formation of impurities in this case would be to continue the exposure for up to 7 or 10 days, so that the study can finally be ended in case there is really no degradation.
If the forced degradation study is okay demonstrating that the methods are stability-indicating, the long-term study associated with the accelerated one will allow the manufacturer to establish an expiry or retest date for the API.
These conclusions are presented in the first part of the stability section, which consists of the stability summary and conclusions.
After that, Post-approval Stability Protocol and Stability Commitment are presented. This is a study done after approval of the API, adding one batch per year in a long-term study.
Finally, the stability data subsection will be where all the results are presented for the studies we have discussed:
- The photostability study
- The forced degradation study
- The accelerated and long-term stability studies - even if they are in progress.
Music: www.bensound.com

Пікірлер: 6
@nileshbawane842
@nileshbawane842 2 ай бұрын
Nice explained...
@muhammadzende1818
@muhammadzende1818 3 ай бұрын
simple & effective. thanks👍
@poonamkamble2976
@poonamkamble2976 13 күн бұрын
Ma'am can you please make a detailed video on new requirements for the CEP content (CEP 2.0). Thank you 😊
@Firoz-lm4sz
@Firoz-lm4sz 3 ай бұрын
Good 👍 But you speak very fast In next video please I request you to speak slow for better understanding.
@FernandaWaechter
@FernandaWaechter 3 ай бұрын
Hi dear, sorry that I have spoken a bit faster to avoid the video from getting even longer. If you want, you can choose a slower speed for the video on youtube itself, and most of what I narrate is also written in the video description. Let me know if there is anything you do not understand
@vasanthdola6768
@vasanthdola6768 2 ай бұрын
​@@FernandaWaechter can you explain about NCE minus one and para iv filing
What is a DMF (drug master file)?
5:40
Fernanda Waechter
Рет қаралды 3,3 М.
Mammalian cell culture
23:37
Neil Cross
Рет қаралды 97 М.
Как бесплатно замутить iphone 15 pro max
00:59
ЖЕЛЕЗНЫЙ КОРОЛЬ
Рет қаралды 8 МЛН
НЫСАНА КОНЦЕРТ 2024
2:26:34
Нысана театры
Рет қаралды 1,4 МЛН
Опасность фирменной зарядки Apple
00:57
SuperCrastan
Рет қаралды 11 МЛН
DMF section 3.2.S.1 - General information
4:02
Fernanda Waechter
Рет қаралды 762
Adam Savage's Latest Flea Market Haul!
11:05
Adam Savage’s Tested
Рет қаралды 168 М.
3 common interview questions on Forced Degradation
21:14
Pharma Growth Hub
Рет қаралды 19 М.
DMF section 3.2.S.3 - Characterization
6:20
Fernanda Waechter
Рет қаралды 822
Water powered timers hidden in public restrooms
13:12
Steve Mould
Рет қаралды 697 М.
What is a Standard Curve?
6:52
ThePenguinProf
Рет қаралды 258 М.
O que é um DMF (drug master file)?
5:39
Fernanda Waechter
Рет қаралды 1,4 М.
DMF section 3.2.S.4 - Control of drug substance
4:32
Fernanda Waechter
Рет қаралды 650
Trick to Remember Stability Climatic Zones as Per ICH Guidelines
6:54